Gentian Diagnostics ASA (OSL:GENT)
Norway
· Delayed Price · Currency is NOK 56.40
+0.80 (1.44%)
Jul 15, 2025, 3:56 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 869.82 million as of July 15, 2025. Its market cap has increased by 25.33% in one year.
Market Cap
869.82M
Enterprise Value
792.73M
Revenue
163.38M
Ranking
n/a
PE Ratio
21.32
Stock Price
56.40
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 869.82M, an increase of 200.33%. That is a compound annual growth rate of 13.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.20B |
| Nordhealth AS | 3.01B |
| Photocure ASA | 1.60B |
| Omda AS | 1.09B |
| Vistin Pharma ASA | 1.06B |
| Thor Medical ASA | 868.97M |
| ArcticZymes Technologies ASA | 842.68M |
| Lytix Biopharma AS | 596.61M |